Laboratorios Farmaceuticos ROVI (ROVI) — Financial Flexibility Index
Laboratorios Farmaceuticos ROVI (ROVI) has a Financial Flexibility Index of 0.31x as of September 2025. Free cash flow of €91.00 Million (operating CF €73.37 Million minus capex €17.62 Million) represents 0% of total liabilities (€289.27 Million). Also explore Laboratorios Farmaceuticos ROVI (ROVI) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Laboratorios Farmaceuticos ROVI Financial Flexibility Index (2006–2024)
Historical Financial Flexibility Index trend for Laboratorios Farmaceuticos ROVI across 19 annual periods. Check ROVI capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Laboratorios Farmaceuticos ROVI (2006–2024)
Year-by-year free cash flow to debt coverage for Laboratorios Farmaceuticos ROVI. For the full company profile including market capitalisation, see Laboratorios Farmaceuticos ROVI market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.80x | €200.50 Million | €138.28 Million | €250.48 Million | ▲ +21.8% |
| 2023 | 0.66x | €168.43 Million | €113.25 Million | €256.39 Million | ▼ -18.8% |
| 2022 | 0.81x | €288.99 Million | €237.60 Million | €357.32 Million | ▲ +11.2% |
| 2021 | 0.73x | €190.38 Million | €149.44 Million | €261.70 Million | ▲ +68.7% |
| 2020 | 0.43x | €86.57 Million | €46.88 Million | €200.74 Million | ▲ +158.7% |
| 2019 | 0.17x | €31.48 Million | €-9.04 Million | €188.82 Million | ▼ -45.1% |
| 2018 | 0.30x | €34.99 Million | €8.53 Million | €115.23 Million | ▼ -14.7% |
| 2017 | 0.36x | €37.98 Million | €18.04 Million | €106.69 Million | ▼ -41.5% |
| 2016 | 0.61x | €63.60 Million | €45.53 Million | €104.44 Million | ▲ +22.4% |
| 2015 | 0.50x | €49.29 Million | €29.39 Million | €99.06 Million | ▲ +6.5% |
| 2014 | 0.47x | €48.06 Million | €23.00 Million | €102.85 Million | ▼ -21.6% |
| 2013 | 0.60x | €54.50 Million | €29.82 Million | €91.46 Million | ▲ +71.5% |
| 2012 | 0.35x | €33.33 Million | €19.61 Million | €95.92 Million | ▲ +88.5% |
| 2011 | 0.18x | €21.04 Million | €12.68 Million | €114.09 Million | ▼ -25.1% |
| 2010 | 0.25x | €26.77 Million | €21.19 Million | €108.75 Million | ▲ +84.3% |
| 2009 | 0.13x | €12.61 Million | €9.62 Million | €94.42 Million | ▼ -57.0% |
| 2008 | 0.31x | €22.40 Million | €12.66 Million | €72.11 Million | ▲ +45.2% |
| 2007 | 0.21x | €12.88 Million | €1.15 Million | €60.23 Million | ▼ -8.7% |
| 2006 | 0.23x | €11.76 Million | €7.72 Million | €50.23 Million | — |